Advances in nanomedicine for head and neck cancer

Frontiers in Bioscience - Landmark

Volumn 19, Issue 5, 2014, Pages 783-788

  Huang, Dong Yan ^a   Hou, Yang Long ^b   Yang, Shi Ming ^a   Wang, Rong Guang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Computed tomography; HNSCC; PET; Review

Indexed keywords

ANTINEOPLASTIC AGENT; NANOPARTICLE; RADIOSENSITIZING AGENT;

GENE THERAPY; HEAD AND NECK TUMOR; HUMAN; NANOMEDICINE; REVIEW; TISSUE DISTRIBUTION;

ANTINEOPLASTIC AGENTS; GENETIC THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NANOMEDICINE; NANOPARTICLES; RADIATION-SENSITIZING AGENTS; TISSUE DISTRIBUTION;

EID: 84904323117     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4245     Document Type: Review

References (45)

1. Yurkov YG Fionov AS, Koksharov YA. Electrical and magnetic properties of nanomaterials containing iron or cobalt nanoparticles. Inorganic Materials 43(8), pp 834-844. (2007)
2. Huang X, Jain PK, EI-Sayed IH. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2(5), 681-693. (2007)
3. Klostergaard J, Seeney CE. Magnetic nanovectors for drug delivery. Nanomedicine Suppl 1, S37-50. (2012)
4. Linic S, Christopher P, Xin H. Catalytic and photocatalytic transformations on metal nanoparticles with targeted geometric and plasmonic properties. AccChem Res 46(8), 1890-1899. (2013)
5. EI-Sayed H. Nanotechnology in head and neck cancer: the race is on. Curr Oncol Rep 12(2), 121-128. (2010)
6. Marites Melancon, Wei Lu, Chun Li. Gold-Based Magneto/Optical Nanostructures: Challenges for In vivoApplications in Cancer Diagnostics and Therapy. Mater Res Bull 34(6), 415-421. (2009)
7. Gilchrist RK, Medal R, Shorey WD. Selective inductive heating of lymph nodes. Ann Surg 146(4), 596-606. (1957)
8. Gordon RT, Hines JR, Gordon D. Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med Hypotheses 5(1), 83-102. (1979)
9. Hilger I, Fruhauf K, Andra W. Heating potential of iron oxides for therapeutic purposes in interventional radiology. AcadRadiol 9(2), 198-202. (2002)
10. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 10(4), 457-483. (1994)
11. Kim J, Park S, Lee JE. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. AngewChemInt Ed Engl 45(46), 7754-7758. (2006)
12. Lim YT, Cho MY, Kim JK. Plasmonic magnetic nanostructure for bimodal imaging and photonic-based therapy of cancer cells. Chembiochem 8(18), 2204-9. (2007)
13. Reuveni T, Motiei M, Romman Z. Targeted gold nanoparticles enable molecular CT imaging of cancer : an in vivo study. Int J Nanomedicine 6, 2859-2864. (2011)
14. Master A, Malamas A, Solanki R. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers. Mol Pharm 10(5), 1988-1997. (2013)
15. Puvanakrishnan P, Park J, Chatterjee D. In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy. Int J Nanomedicine 7, 1251-1258. (2012)
16. Giulio F, Paciotti, David GI. Kingston, Lawrence Tamarkin. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug development research 67(1), 47-54. (2006)
17. Rivkin I, Cohen K, Koffler J. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 31(27), 7106-7114. (2010)
18. Bachar G, Cohen K, Hod R. Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers. Biomaterials 32(21), 4840-4848. (2011)
19. Trimble C, Lin CT, Huang CF. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21, 4036-4042. (2003)
20. Rezler EM, Khan DR, Tu R. Peptide-mediated targeting of liposomes to tumor cells. Methods Mol. Biol 386, 269-298. (2007)
21. Neves SS, Sarmento-Ribeiro AB, Simoes SP. Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: Mechanisms of cell death induced by herpes simplex virus thymidine kinase/ganciclovir therapy. Biochim.Biophys.Acta 1758, 1703-1712. (2006)
22. Dolivet G, Merlin JL, Barberi-Heyob M. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylatedpolyethyleniminenonviral vector. Cancer Gene Ther 9(8), 708-714. (2002)
23. Hainfeld JF, Dilmanian FA, Slatkin DN. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 60(8), 977-985. (2008)
24. Hainfield JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49(18), N309-315. (2004)
25. Townley HE, Rapa E, Wakefield G. Nanoparticle augmented radiation treatment decreases cancer cell proliferation. Nanomedicine 8(4), 526-36. (2012)
26. Hilliard L, Kutscher, Piyun Chao, Manjeet Deshmukh. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. J Control Release 143(1), 31-37. (2010)
27. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66(17), 2873-2896. (2009)
28. Choi HS, Liu W, Misra P. Renal clearance of quantum dots. Nat Biotechnol 25(10), 1165-1170. (2007)
29. Kettiger H, Schipanski A, Wick P. Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomedicine 8, 3255-3269. (2013)
30. Arnida, Janat-Amsbury MM, Ray A. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77(3), 417-423. (2011)
31. Harush-Frenkel O, Altschuler Y, Benita S. Nanoparticle-cell interactions: drug delivery implications. Crit Rev Ther Drug Carrier Syst 25(6), 485-544. (2008)
32. Li SD, Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release 145(3), 178-181. (2010)
33. Ishihara T, Takeda M, Sakamoto H. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res 26(10), 2270-2279. (2009)
34. Xie H, Goins B, Bao A. Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells. Int J Nanomedicine 7, 2227-2238. (2012)
35. Rossin R, Pan D, Qi K. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med 46(7), 1210-1218. (2005)
36. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4), 662-668. (2006)
37. Lu F, Wu SH, Hung Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5(12), 1408-1413. (2009)
38. Aggarwal P, Hall JB, McLeland CB. Nanoparticle interaction with plasma proteins as it relateds to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61(6), 428-437. (2009)
39. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1), 93-102. (2006)
40. Nie S. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) 5(4), 523-528. (2010)
41. Lunov O, Syrovets T, Loos C. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5(3), 1657-1659. (2011)
42. Zhu MT, Feng WY, Wang Y. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci 107(2), 342-351. (2009)
43. Ye L, Yong KT, Liu L. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat Nanotechnol 7(7), 453-458. (2012)
44. Filipe V, Poole R, Kutscher M. Fluorescence single particle tracking for the characterization of submicron protein aggregates in biological fluids and complex formulations. Pharm Res 28(5), 1112-20. (2011)
45. Xiang S, Tong H, Shi Q. Uptake mechanisms of nonviral gene delivery. J Control Release 158(3), 371-378.(2012)